Bristol-Myers Squibb
Managing Emotional Distress in Alzheimer's Disease
Pages
2
Time to read
2 mins
Publication
Language
English
Pages
2
Time to read
2 mins
Publication
Language
English
This guide addresses the recognition and management of emotional distress and restlessness in individuals with Alzheimer's disease. It outlines how changes in brain proteins, specifically amyloid and tau, affect cell function, leading to behavioral symptoms in up to 70% of patients. Agitation, characterized by irritability and restlessness, is highlighted as a common symptom, often stemming from fear, confusion, or physical needs rather than anger. The guide provides practical strategies for caregivers to manage agitation, such as maintaining a predictable routine, offering simple choices, and checking for physical needs. It also emphasizes the importance of creating a support network, suggesting that caregivers reach out to family, friends, and local organizations for assistance. The document underscores that caregivers are not alone in their challenges and encourages them to seek help from healthcare teams and community resources. Overall, it serves as a resource for understanding the complexities of caregiving for individuals with Alzheimer's disease.